Navigation Links
Targanta in Medical Technology

Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria

... CHICAGO, Sept. 19 /PRNewswire/ -- targanta Therapeutics Corporation today released detailed d...s (cSSSI) in which the primary endpoints were met. targanta believes oritavancin's properties may give it dist...ize oritavancin for the treatment of cSSSI. About targanta Therapeutics ...

Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models

...overy Platform CHICAGO, Sept. 19 /PRNewswire/ -- targanta Therapeutics Corporation today released detailed d...tration (FDA) as a significant unmet medical need. targanta has developed a novel drug discovery platform thro...nt as a possible therapy for osteomyelitis. About targanta Therapeutics ...

Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria

... Vitro Methods CHICAGO, Sept. 19 /PRNewswire/ -- targanta Therapeutics Corporation today released data from ...lls (5- to 13-fold lower MICs against the spores); targanta believes that such a phenomenon has not been repor...s (cSSSI) in which the primary endpoints were met. targanta believes oritavancin's properties may give it dist...

Targanta Initiates Phase 2 Oritavancin Infrequent Dosing Study

...cSSSI CAMBRIDGE, Mass., Sept. 13 /PRNewswire/ -- targanta Therapeutics Corporation today announced the initi...amine safety data in all intent-to-treat patients. targanta expects to enroll a total of 300 patients in this ...n (cSSSI) in which the primary endpoints were met. targanta believes oritavancin's properties may give it dist...

Targanta Reports Improved Ability of Oritavancin to Stop Bacteria Growth In Vitro Compared With Other Glycopeptide Antibiotics

...said Thomas Parr, Ph.D., Chief Scientific Officer, targanta Therapeutics. "These data further support oritavan...al treatment for serious bacterial infections, and targanta will continue to explore this potential through on...med by former developers Lilly and InterMune, Inc. targanta expects to file a New Drug Application (NDA) for o...

Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax

...val rate at 30 days. Researchers at USAMRIID and targanta concluded that their results provide impetus for i...velopers Eli Lilly and Company and InterMune, Inc. targanta expects to file a New Drug Application (NDA) for o...ministration in the first quarter of 2008. About targanta Therapeutics Corporation ...
Targanta in Biological Technology

InterMune Reports First Quarter 2009 Financial Results and Business Highlights

...ly $6.0 million received in the first quarter of 2009 from the acquisition by The Medicines Company of InterMune's approximately 3.0 million shares of targanta Therapeutics Corporation. On January 1, 2009, the company adopted Financial Accounting Standards Board Staff Position APB 14-1, "Accounting fo...

InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights

... completed its tender offer for all of the outstanding shares of targanta Therapeutics Corporation. Based on InterMune's ownership of approximately 3 million targanta shares, InterMune expects to receive approximately $6.0 million in t...

Targanta Submits Oritavancin New Drug Application

...lizations, and increased healthcare costs. About targanta Therapeutics targanta Therapeutics Corporation is a biopharmaceutical co...d Montreal, Quebec, Canada. To find out more about targanta Therapeutics Corp. (Nasdaq: TARG ), visit our web...

InterMune Announces Fourth Quarter and Full Year 2007 Financial Results and Provides 2008 Guidance

...lion, compared with $214.5 million at December 31, 2006. In October 2007, targanta Therapeutics completed an initial public offering of its common stock, which resulted in the conversion of InterMune's interest in targanta into approximately 3.0 million shares of Targanta common stock. As of Decem...

Targanta to Present at Lazard Capital Markets Fourth Annual Healthcare Conference

...ite at http://www.targanta.com/investors . About targanta Therapeutics targanta Therapeutics Corporation is a biopharmaceutical co...i-synthetic lipoglycopeptide antibiotic, for which targanta intends to seek U.S. regulatory approval in early ...

Targanta to Present at 9th Annual Mass Opportunities Investment Conference

...ite at http://www.targanta.com/investors . About targanta Therapeutics targanta Therapeutics Corporation is a biopharmaceutical co...i-synthetic lipoglycopeptide antibiotic, for which targanta intends to seek U.S. regulatory approval in early ...

Biotech Continues Upward Climb in October

... offering at $12, 20% below the midpoint of their proposed $14 to $16 range. During the month its shares strengthened to close at $13.88. -- targanta Therapeutics, which developing an antibiotic treatment for gram-positive bacterial infections, priced 5.8 million shares at $10 per share, 30%...

2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies

...ticals, Molecular, Biometrics, Molecular Insight Pharmaceuticals, Momenta Pharmaceuticals, Nitromed Inc., Oscient Pharmaceuticals, Primera Biosystems, targanta Therapeutics, Transmolecular Inc, Transport Pharmaceuticals, Vertex Pharmaceuticals, and Ziopharm. Last year was a banner year for venture capital fi...

Targanta Therapeutics Announces Pricing of its Initial Public Offering

.... All of the shares are being offered by Targanta. targanta has granted to the underwriters a 30-day option to...ies laws of any such state or jurisdiction. About targanta Therapeutics targanta Therapeutics Corporation is a biopharmaceutical co...

Targanta Therapeutics to Have Significant Presence at 47th Annual ICAAC Meeting

...eting CAMBRIDGE, Mass., Sept. 12 /PRNewswire/ -- targanta Therapeutics Corporation today announced that 23 p.... Thomas Parr, Ph.D., Chief Scientific Officer of targanta Therapeutics commented on the meeting: "We are ver...d of the body of data being presented on behalf of targanta at ICAAC this year-a true testament, we believe, t...
Other Tags
(Date:4/18/2015)... (PRWEB) April 18, 2015 “ ArcAngel ” ... which takes a look at the latest and coolest ... Joe Troohey, the host of AppWatch and technology expert, conducted ... a personal safety app. , In a turbulent world, ... help. Calling 911 should always be their first move, but ...
(Date:4/17/2015)... Heritage Woods of McLeansboro, a Gardant affordable ... Celebration on April 20 with a day full of ... and soul. , The community, which is located at ... of all incomes, including those on Medicaid, who need ... Week is observed every April and highlights the communities ...
(Date:4/17/2015)... April 17, 2015 ERGO-Pedic Products, LLC, ... introducing two new products to help a broader range ... pain relief are the second most common visitors to ... product, designed specifically to help relieve sitting pain. Then, ... and thousands of happy customers later, we began getting ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at ... were all selected as Top Workplaces in Tampa Bay. ... is ranked number one for large businesses according to ... in partnership with an independent research firm. Florida Hospital ... opened in October of 2012 with a vision of ...
(Date:4/17/2015)... In Defense of Christians (IDC) Executive Director ... April 15th, the European Parliament joined its voice with ... Armenian Genocide, “paying tribute, on the eve of the ... Armenian victims who perished in the Ottoman Empire.” ... this timely and needed recognition of a tragic episode ...
Breaking Medicine News(10 mins):Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3
(Date:3/17/2015)... MINNETONKA, Minn. , March 17, 2015 /PRNewswire/ ... sciences technology company specializing in clinical study management ... will be in attendance at ARENA,s Outsourcing in ... Cary, NC.  This event provides an excellent forum ... company,s easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical ...
(Date:3/17/2015)... 2015  MecklerMedia Corporation (OTCQX: MECK) announced its ... robots ever held in New York ... 11-13, 2015 at the Javits Convention Center. ... include: Acorn Product Development; Axis NJ; c-Link Systems; ... Littler; NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; ...
(Date:3/12/2015)... 12, 2015 IriTech, a leading iris based ... the Texas Instruments Design Network, announced today that the ... its IriShield USB MK2120U device during a launching event ... distribution. The iris scanner is manufactured ... in India through its Indian ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
Other Contents